EGFR and melanoma: Treatment with rosmarinic acid significantly reduced cell viability, proliferation, migrative and invasive abilities, and chemotherapy sensitivity of melanoma cells through inhibition of the ADAM17/EGFR/AKT/GSK3β axis [113].